Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02317952Not ApplicableCompleted

Formula for Children With Cow's Milk Allergy

Role: lead

NCT01497314Not ApplicableCompleted

Growth and Safety of a Low Lactose Milk-Based Infant Formula

Role: lead

NCT00938483Not ApplicableCompleted

Tolerability and Safety of An Infant Formula

Role: lead

NCT00936637Not ApplicableCompleted

Effects on Growth of an Extensively Hydrolyzed Formula Fed to Term

Role: lead

All 4 trials loaded